Jarrod A Call1, Kristopher H Chain1, Kyle S Martin1, Vitor A Lira1, Mitsuharu Okutsu1, Mei Zhang1, Zhen Yan2. 1. From the Departments of Medicine (J.A.C., K.H.C., V.A.L., M.O., M.Z., Z.Y.), Pharmacology (Z.Y.), Molecular Physiology and Biological Physics (Z.Y.), Center for Skeletal Muscle Research at the Robert M. Berne Cardiovascular Research Center (J.A.C., K.H.C., V.A.L., M.O., M.Z., Z.Y.), and Department of Biomedical Engineering (K.S.M.), University of Virginia, Charlottesville. 2. From the Departments of Medicine (J.A.C., K.H.C., V.A.L., M.O., M.Z., Z.Y.), Pharmacology (Z.Y.), Molecular Physiology and Biological Physics (Z.Y.), Center for Skeletal Muscle Research at the Robert M. Berne Cardiovascular Research Center (J.A.C., K.H.C., V.A.L., M.O., M.Z., Z.Y.), and Department of Biomedical Engineering (K.S.M.), University of Virginia, Charlottesville. zhen.yan@virginia.edu.
Abstract
BACKGROUND: Exercise training enhances extracellular superoxide dismutase (EcSOD) expression in skeletal muscle and elicits positive health outcomes in individuals with diabetes mellitus. The goal of this study was to determine if enhanced skeletal muscle expression of EcSOD is sufficient to mitigate streptozotocin-induced diabetic cardiomyopathy. METHODS AND RESULTS: Exercise training promotes EcSOD expression in skeletal muscle and provides protection against diabetic cardiomyopathy; however, it is not known if enhanced expression of EcSOD in skeletal muscle plays a functional role in this protection. Here, we show that skeletal muscle-specific EcSOD transgenic mice are protected from cardiac hypertrophy, fibrosis, and dysfunction under the condition of type 1 diabetes mellitus induced by streptozotocin injection. We also show that both exercise training and muscle-specific transgenic expression of EcSOD result in elevated EcSOD protein in the blood and heart without increased transcription in the heart, suggesting that enhanced expression of EcSOD from skeletal muscle redistributes to the heart. Importantly, cardiac tissue in transgenic mice displayed significantly reduced oxidative stress, aberrant cell signaling, and inflammatory cytokine expression compared with wild-type mice under the same diabetic condition. CONCLUSIONS: Enhanced expression of EcSOD in skeletal muscle is sufficient to mitigate streptozotocin-induced diabetic cardiomyopathy through attenuation of oxidative stress, aberrant cell signaling, and inflammation, suggesting a cross-organ mechanism by which exercise training improves cardiac function in diabetes mellitus.
BACKGROUND: Exercise training enhances extracellular superoxide dismutase (EcSOD) expression in skeletal muscle and elicits positive health outcomes in individuals with diabetes mellitus. The goal of this study was to determine if enhanced skeletal muscle expression of EcSOD is sufficient to mitigate streptozotocin-induced diabetic cardiomyopathy. METHODS AND RESULTS: Exercise training promotes EcSOD expression in skeletal muscle and provides protection against diabetic cardiomyopathy; however, it is not known if enhanced expression of EcSOD in skeletal muscle plays a functional role in this protection. Here, we show that skeletal muscle-specific EcSODtransgenic mice are protected from cardiac hypertrophy, fibrosis, and dysfunction under the condition of type 1 diabetes mellitus induced by streptozotocin injection. We also show that both exercise training and muscle-specific transgenic expression of EcSOD result in elevated EcSOD protein in the blood and heart without increased transcription in the heart, suggesting that enhanced expression of EcSOD from skeletal muscle redistributes to the heart. Importantly, cardiac tissue in transgenic mice displayed significantly reduced oxidativestress, aberrant cell signaling, and inflammatory cytokine expression compared with wild-type mice under the same diabetic condition. CONCLUSIONS: Enhanced expression of EcSOD in skeletal muscle is sufficient to mitigate streptozotocin-induced diabetic cardiomyopathy through attenuation of oxidativestress, aberrant cell signaling, and inflammation, suggesting a cross-organ mechanism by which exercise training improves cardiac function in diabetes mellitus.
Authors: Yi Chu; Robert Piper; Simon Richardson; Yoshimasa Watanabe; Pragnesh Patel; Donald D Heistad Journal: Arterioscler Thromb Vasc Biol Date: 2006-06-29 Impact factor: 8.311
Authors: Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano Journal: JAMA Date: 2008-11-09 Impact factor: 56.272
Authors: Chun-Hong Shao; Xander H T Wehrens; Todd A Wyatt; Sheeva Parbhu; George J Rozanski; Kaushik P Patel; Keshore R Bidasee Journal: J Appl Physiol (1985) Date: 2009-01-08
Authors: Ashwani Malhotra; Barinder P S Kang; Himanshu Vashistha; Virender S Yadav; Leonard G Meggs Journal: Can J Physiol Pharmacol Date: 2008-03 Impact factor: 2.273
Authors: Di Cui; Joshua C Drake; Rebecca J Wilson; Robert J Shute; Bevan Lewellen; Mei Zhang; Henan Zhao; Olivia L Sabik; Suna Onengut; Stuart S Berr; Stephen S Rich; Charles R Farber; Zhen Yan Journal: FASEB J Date: 2020-04-18 Impact factor: 5.191
Authors: Jarrod A Call; Jean Donet; Kyle S Martin; Ashish K Sharma; Xiaobin Chen; Jiuzhi Zhang; Jie Cai; Carolina A Galarreta; Mitsuharu Okutsu; Zhongmin Du; Vitor A Lira; Mei Zhang; Borna Mehrad; Brian H Annex; Alexander L Klibanov; Russell P Bowler; Victor E Laubach; Shayn M Peirce; Zhen Yan Journal: Free Radic Biol Med Date: 2017-10-02 Impact factor: 7.376
Authors: Arkady Uryash; Jorge Bassuk; Paul Kurlansky; Francisco Altamirano; Jose R Lopez; Jose A Adams Journal: PLoS One Date: 2015-07-02 Impact factor: 3.240